Literature DB >> 12894090

Necrolytic migratory erythema as the only presenting sign of a glucagonoma.

Sandra Marchese Johnson1, Bruce R Smoller, Laura W Lamps, Thomas D Horn.   

Abstract

We describe a 39-year-old man with a 3-year history of a recalcitrant psoriasiform eruption that was accentuated in the intertriginous areas. Hsitopathology was consistent with psoriasis. A glucagon level was 744 pg/mL with the upper limit of normal being 130 pg/mL. Computed tomographic scan of the abdomen revealed a 5-cm mass in the tail of the pancreas. The tumor was removed and found to be a glucagonoma (pancreatic islet tumor). The clinical eruption resolved promptly with surgical excision. Neither the clinical eruption nor the tumor has recurred for 6 months. The course of disease confirms the diagnosis of necrolytic migratory erythema associated with a glucagonoma.

Entities:  

Mesh:

Year:  2003        PMID: 12894090     DOI: 10.1067/s0190-9622(02)61774-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Reversible dilated cardiomyopathy associated with glucagonoma.

Authors:  K Chang-Chretien; J T Chew; D P Judge
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

2.  Necrolytic migratory erythema as the first manifestation of glucagonoma.

Authors:  Abolfazl Afsharfard; Khashayar Atqiaee; Saran Lotfollahzadeh; Majid Alborzi; Amir Derakhshanfar
Journal:  Case Rep Surg       Date:  2012-08-27

3.  Glucagonoma syndrome: a case report with focus on skin disorders.

Authors:  Sheng Fang; Shuang Li; Tao Cai
Journal:  Onco Targets Ther       Date:  2014-08-14       Impact factor: 4.147

4.  Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.

Authors:  Sheng-li Wu; Ji-gang Bai; Jun Xu; Qing-yong Ma; Zheng Wu
Journal:  World J Surg Oncol       Date:  2014-07-17       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.